Lupin and the Municipal Corporation of Greater Mumbai (MCGM) have united and launched a joint campaign to detect and address active cases of TB in Mumbai. The door-to-door Active Case Finding (ACF) campaign will cover all high-risk population areas selected from all 24 wards under the MCGM.
This campaign and the methodology of execution follows the success of ACF pilot that was conducted by Lupin along with the TB department of the MCGM in 2017. The new 12-month project will involve comprehensive end-to-end TB detection, treatment and follow-up with door-to-door visits conducted in high-risk areas to identify symptomatic patients.
Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.
